Author： Olver J.S. Burrows G.D. Norman T.R.
Publisher： Adis International
ISSN： 1172-7047
Source： CNS Drugs, Vol.15, Iss.12, 2001-01, pp. : 941-954
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
The Second Generation of COX-2 Inhibitors: What Advantages Do the Newest Offer?
By Stichtenoth D.O. Frölich J.C.
Drugs, Vol. 63, Iss. 1, 2003-01 ,pp. :
Access to resources
Recommend
Increased risk of MI with tricyclics, but not SSRIs?
Inpharma, Vol. 1, Iss. 1224, 2000-01 ,pp. :
COX-2 Selective Nonsteroidal Anti-Inflammatory Drugs: Do They Really Offer Any Advantages?
Drugs, Vol. 59, Iss. 6, 2000-06 ,pp. :
Aldosterone Receptor Antagonists for Hypertension: What Do They Offer?
Drugs, Vol. 63, Iss. 19, 2003-01 ,pp. :